Cook’s Zilver PTX Peripheral Drug-Eluting Stent Sails Through FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Cook Medical’s first-of-a-kind Zilver PTX percutaneous paclitaxel-eluting peripheral stent received unanimous and enthusiastic support from the FDA’s Circulatory System Devices panel last week.
You may also be interested in...
Research In Brief
Recent data and study announcements in cardiac, neuro and diabetes.
New Products In Brief
Abbott’s Absolute Pro iliac stent and Enzo Biochem’s ColonSentry colorectal cancer test are among newly approved devices.
Cook Medical Makes Its Case For Medicare New-Tech Add-On Payments
Cook is seeking add-on payments for its Zilver PTX drug-eluting peripheral stent and Zenith AAA endovascular graft in 2013, addressing related CMS questions at a Feb. 14 new-technology “town hall” meeting.